Sales Lead – Named Patient Programs (Oncology, Rare Disease & Critical Care)

About the Company Sowaka Health is building the first compliance‑native platform for named‑patient and early access programs in India and underserved markets globally. Through our proprietary platform, SowakaOS , we operate specialty access and named‑patient programs for unapproved and hard‑to‑access medicines, working with hospitals, physicians, and global suppliers to create safe, audit‑ready “port‑to‑patient” pathways. In markets where patients needing pre‑commercial or unlicensed breakthrough therapies have limited structured, credible access routes, we are creating that pathway from the ground up with the intent to make it the global standard.

Role Purpose The Sales Lead – Named Patient Progra ms is a foundational Indi a commercial access and physician‑engageme nt role, responsible for building specialist awareness, developing deep physician relationships, and generating qualified, compliant case flow for Sowaka’s patient‑linked access programs in oncology, rare disease, and critical car e.This is a highly hands‑on field role that combines specialist engagement, access pathway education, structured field intelligence, and disciplined follow‑through with treating clinicians and institutional teams. It i s not a traditional promotional pharma sales ro le; success depends on credible, non‑promotional, access‑focused conversations with senior clinicians across Indi a.You will work closely with the founding team, access operations, sourcing, logistics, regulatory, quality, PV, and institutional access teams to ensure that physician‑driven opportunities are properly qualified, documented, and transferred into executable access workflow s. Key responsibili ties1.

Physician engagement & specialist access develop mentIdentify, engage, and develop relationships with oncologists, hematologists, speciality physicians, KOLs, clinical department heads, and treatment teams across key centres in In dia.Conduct regular field engagement with priority oncology centres, cancer hospitals, speciality clinics, and institutional clinical departments (pan‑India travel as requir ed).Build awareness of Sowaka’s compliant access infrastructure, named‑patient pathways, documentation expectations, and case initiation processes—without promoting specific products or influencing treatment decisi ons.Maintain structured engagement with physicians who may encounter patients requiring access to unavailable, delayed, or hard‑to‑source speciality therap ies.Develop city‑wise and disease‑area physician maps across priority oncology and speciality care segments in In dia. 2. Access pathway education & case facilit ationEducate physicians and clinical teams on physician‑led access request processes, documentation requirements, treatment‑continuity considerations, and operational workf lows.Guide treating clinicians toward appropriate intake and documentation procedures when they identify a patient‑linked access need.Ensure access inquiries originate from treating physicians or appropriate clinical stakeholders and are routed into company‑approved intake workf lows.Coordinate with internal teams so that physician questions, documentation needs, and clinical clarifications are addressed in a timely and compliant ma nner.Support case progression by helping physicians understand required clinical documents, prescriptions, treatment rationale, and follow‑up requirements; escalate urgent cases, documentation gaps, or timeline risks to internal leader ship. 3. Oncology intelligence & field fe edbackCapture structured field intelligence on unmet medical needs, therapy access gaps, oncology treatment trends, physician concerns, and patient access barriers in the Indian co ntext.Track disease areas, therapies, and clinical scenarios where access needs are recurring or strategically rel evant.Provide clear feedback to leadership on physician perspectives, institutional barriers, and competitive access models in India.Support internal understanding of the India oncology and speciality‑care landscape, including priority centres, KOL networks, referral patterns, and treatment‑access gaps.Contribute to development of compliant physician‑education materials, access pathway explainers, briefing notes, and field engagement tools. 4.

Commercial access pipeline & internal coord inationGenerate qualified, physician‑led access opportunities through compliant engagement with oncologists and speciality phys icians.Qualify physician inquiries based on patient‑linked need, seriousness, documentation readiness, operational feasibility, and complian ce fit.Coordinate with institutional access, sourcing, logistics, regulatory, quality, PV, and operations teams to determine whether opportunities can be executed respo nsibly.Maintain accurate records of physician meetings, access inquiries, case referrals, clinical insights, follow‑ups, and internal hand‑offs using company‑approved CRM/trackers/SharePoint and SowakaOS wor kflows.Provide regular updates on physician‑engagement progress, case pipeline, field insights, risks, and next steps.5. Team build‑out & field dis ciplineHelp establish the physician‑engagement model, field cadence, reporting discipline, and compliant communication standards for future access‑engagement teams in India.Support onboarding and mentoring of future field or access‑engagement team members as volume and geography expand.Model professional behaviour, responsiveness, documentation discipline, and boundary management in all physician‑facing intera ctions.Coordinate with external India sales/access advisors where engaged, ensuring introductions and field insights are captured in structured, company‑owned s ystems. Who sho uld applyThis role is best suited for candid ates who:Have strong existing or potential physician relationships in oncology, haematology, speciality pharma, rare disease, or high‑acuity therapeut ic areas.Can engage senior clinicians credibly and professionally while maintaining strict compliance bo undaries.Are comforta ble with hands‑on f ield work (hospital/clinic travel, regular physician meetings) and immediate opportunity dev elopment.Can translate physician conversations into structured, documented, and actionable access oppor tunities.Are comfortable work ing in a founder‑stage en vironment where commercial systems and field processes are still being built, and can balance urgency with disciplined, non‑promotional commu nication.

Experience & qua lificati onsRequir ed5–8 years of experience in oncology pharma sales, speciality pharma sales, medical affairs/MSL roles, KOL engagement, patient access, hospital relations, or related physician‑facing healthcare role s in India.Demonstrated ability to engage oncologists, haematologists, speciality physicians, or senior clinical stakeholders in the Ind ian market.Strong understanding of oncology/speciality medicine environments, treatment pathways, clinical‑stakeholder dynamics, and physician‑engagement norm s in India.Ability to communicate access‑pathway concepts clearly without making promotional claims or influencing clinical decisions.Strong written and verbal communication skills in English; fluency in Hindi or other regional languages is a plus for field work.High responsiveness, field ownership, follow‑through discipline, and comfort operating in dynamic, founder‑stage en vironments.Willingness to travel regularly across India for physician meetings and institutio nal visit s. PreferredExisting relationships with oncologists, haematologists, KOLs, cancer centres, or speciality physicians in key I ndian metros.Experience in oncology, rare disease, biologics, speciality medicines, patient support/access programs, or high‑val ue therapies.Prior exposure to named‑patient programs, expanded access programs, compassionate use, medical affairs, or patient‑acce ss functions.Experience working with multinational pharma, speciality healthcare providers, or healthcare start ups in India.Comfort using CRM tools, structured reporting systems, and documentation repositories CompensationPerformance and growth-linked compensation progression will evolve alongside operational scale and organisat ional buildout.